If you are:
Only When Necessary:
Only When Necessary: EVIDENCE FOR MALFORMATIONS; CAN REDUCE UTERINE BLOOD FLOW CAUSING FETAL HYPOXIA
FDB Only When Necessary: COMPATIBLE PER BRIGGS;OVERWHELMING HUMAN AND ANIMAL DATA SUGGESTS COMPATIBILITY
No Known Risk: LOW LEVELS EXCRETED WITH LOW RISK FOR ADVERSE EFFECTS IN INFANT
Precaution: INSUFFICIENT DATA AVAILABLE; MOLECULAR WT LOW ENOUGH FOR POSSIBLE EXCRETION
Precaution: ORAL BIOAVAILABILITY LOW; INFANT EXPOSURE MAY BE MINIMAL
Precaution: LOW MOLEC WT. POSSIBLE EXCRETION; NOT RECOM; MAY CAUSE PARADOXICAL EXCITATION
An adult over 60:
management or monitoring precaution: Cardiovascular-Elderly are more sensitive to tachycardia and hypertensive effects. May exacerbate symptomatic coronary insufficiency. Genitourinary-May cause urinary retention. Neuro/Psych-May worsen cognitive impairment in some elderly with dementia. Insomnia risk.
management or monitoring precaution: Neuro/Psych-Anticholinergic effects may cause sedation, worsen cognitive impairment and increase fall risk. Non-sedating antihistamine preferred. Gastrointestinal-May cause or worsen pre-existing constipation. Genitourinary-Best avoided in patients with urinary retention from any cause.
management or monitoring precaution: Hepatic-Elderly are more susceptible to hepatotoxicity. Strict adherence to a maximum daily dose of 3000mg is advised.
Giving DM-PE-acetam/DM-acetam-doxylam Capsule, Sequential to a child under 12:
management or monitoring precaution: Use weight based dosing in children less than 12 years.
Severe Precaution: Not recommended age < 6 years without clinician consultation.
Contraindication: Do not use in pediatrics <6 years of age unless clinician consultation.
Contraindication: CNS excitation and convulsion risk in newborns. Not recommended age <2 years.
Contraindication: Risk of CNS excitation. Do not use age <6 years without clinician consult.